Tele: 561.316.3330
Breaking Medical Device News

Thursday, September 23, 2021

HomeEXECUTIVESDavid Hemink Named New CEO of Nonin Medical

David Hemink Named New CEO of Nonin Medical

David Hemink has been named the new CEO of Nonin Medical effective February 11, 2019.  Hemink succeeds Nonin founder, Philip Isaacson, as CEO. Isaacson will remain as chief technology officer, and take on the responsibility of executive chairman.

“I have a great sense of accomplishment in guiding Nonin Medical since the founding of the company in 1986; I am proud of our achievements and how we have been able to improve the quality of people’s lives through our innovation,” said Isaacson. “With his passion, leadership and industry experience, the board and I are confident that David is the right person to continue to drive continued innovation and growth well into the future.”

Hemink has extensive experience as a leader and innovator in the medical device industry. Before joining Nonin as Executive Vice President of Sales in August 2018, he served as president of Cantel Medical, a leading provider of infection prevention products and services. At Cantel, he helped to drive significant, profitable growth and developed innovative infection prevention and control technologies that measurably improved outcomes for caregivers and patients alike.

Prior to Cantel, Mr. Hemink served as senior vice president of electrophysiology at Boston Scientific, a renowned global medical technology leader, and president of Bard Access Systems, a market leader in vascular access devices. Earlier in his career, he held senior sales and marketing roles at Abbott Vascular Devices, Dell EMC, and Boston Scientific. Hemink received his Master of Business Administration from the Kellogg School of Management at Northwestern University and a Bachelor of Arts in Speech Communications from California State University, Fresno.

“I know I speak for everyone at Nonin in thanking Phil for his dedication and leadership to the company,” said Hemink.  “I am excited by the opportunity to lead Nonin Medical, a company rich with talent, capability and technology platforms that have a long standing history of success and delivering best-in-class care.”

“I’ve had the privilege to support caregivers and patients, for over 25 years in the medical device field, and I am thrilled to be working with such a strong team as we look to future innovation and advancements within the next chapter at Nonin Medical,” continued Hemink.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy